Per the AASLD (American Association for the Study of Liver Disease)
Recommended and alternative regimens listed alphabetically for:
Treatment-Naive Genotype 3 Patients Without Cirrhosis
Daily fixed-dose combination of glecaprevir (300 mg)/pibrentasvir (120 mg) for 8 weeks
Daily fixed-dose combination of sofosbuvir (400 mg)/velpatasvir (100 mg) for 12 weeks
Daily daclatasvir (60 mg)b plus sofosbuvir (400 mg) for 12 weeks
The medication you should take should be determined by your doctor.
I believe the 2 newest meds that were approved in the US were Vosevi and Mavyret. I don't know what meds are approved right now in Pakistan. I think that sometimes some drugs are approved in some countries and not in others. These drugs are pan-genotropic. Not sure if I'm saying that right. Anyhow, what that means is that they covered multiple genotypes, like Geno 1-6. If you google them, you can find out more details about them.